Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3399696

NC(=O)Cc1ccc(Cl)c(Cl)c1.O=C(O)C(F)(F)F

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 2/20 0.46
HTR2A P28223 1/20 0.46
PIK3CA P42336 1/20 0.44
FDPS P14324 1/20 0.44
CA2 P00918 2/20 0.44
KMT2A Q03164 2/20 0.43
SLC6A2 P23975 1/20 0.43
SLC6A3 Q01959 1/20 0.43
HSP90AA1 P07900 2/20 0.42
POLB P06746 1/20 0.42
IDO1 P14902 2/20 0.41
FFAR1 O14842 1/20 0.41
LMNA P02545 1/20 0.41
PNMT P11086 1/20 0.41
TAAR1 Q96RJ0 1/20 0.41
TSHR P16473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1029174 0.88 SLC6A4 (0.54) SLC6A4HTR2APIK3CAFDPSCA2
Trifluoroacetic Acid SCHEMBL5659578 0.81 CA2 (0.50) CA2
Trifluoroacetic Acid SCHEMBL6379652 0.81 TAAR1 (0.68) FDPSKMT2ASLC6A2SLC6A3IDO1
Trifluoroacetic Acid SCHEMBL6379095 0.79 HTR3E (0.54) PIK3CAKMT2APNMT
SCHEMBL31481163 0.79 IDO1 (0.57) CA2IDO1
SCHEMBL5264425 0.79 IDO1 (0.57) CA2IDO1
SCHEMBL12499754 0.78 KMT2A (0.40) PIK3CAFDPSCA2KMT2AHSP90AA1
SCHEMBL12499758 0.78 KMT2A (0.40) PIK3CAFDPSCA2KMT2AHSP90AA1
Trifluoroacetic Acid SCHEMBL6257839 0.76 TSHR (0.54) SLC6A4KMT2ASLC6A2SLC6A3FFAR1
Trifluoroacetic Acid SCHEMBL5657716 0.76 CA2 (0.52) CA2KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110053985-A1 NOVEL PIPERIDINE-4-CARBOXYLIC ACID PHENYL-ALKYL-AMIDE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS NEUROSEARCH A/S (DK) 2011-03-03 US disclosed
EP-2245011-A1 NOVEL PIPERIDINE-4-CARBOXYLIC ACID PHENYL-ALKYL-AMIDE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS NeuroSearch A/S (DK) 2010-11-03 EP disclosed
WO-2009090173-A1 NOVEL PIPERIDINE-4-CARBOXYLIC ACID PHENYL-ALKYL-AMIDE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS NEUROSEARCH A/S (DK) 2009-07-23 WO disclosed
EP-1150946-B1 ARYLALKANOYL DERIVATIVES, PROCESSES FOR THEIR PREPARATION, THEIR USE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AVENTIS PHARMA GMBH (DE) 2005-03-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110053985-A1 NOVEL PIPERIDINE-4-CARBOXYLIC ACID PHENYL-ALKYL-AMIDE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS SLC18A2, SLC6A2, SLC18A3 SLC6A4 4/4885HTR2A 43/4885PIK3CA 1367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.